CD44 standard form expression as a predictor of progression in high risk superficial bladder tumors

International Urology and Nephrology

Volumn 33, Issue 3, 2001, Pages 479-483

  Stavropoulos, Nickolaos E ^a   Filliadis, Ioannis ^a   Ioachim, Elli ^b   Michael, Michael ^b   Mermiga, Efpraxia ^a   Hastazeris, Konstantinos ^a   Nseyo, Unyime O ^c  

^a G HATZIKOSTA GENERAL HOSPITAL   (Greece)

^b UNIVERSITY OF IOANNINA   (Greece)

^c VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Bladder cancer; CD44; Progression

Indexed keywords

HERMES ANTIGEN; TUMOR MARKER;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; BLADDER CARCINOMA; CANCER GRADING; CANCER GROWTH; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CARCINOMA IN SITU; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PREDICTION; PROGNOSIS; TRANSITIONAL CELL CARCINOMA; TRANSURETHRAL RESECTION; BLADDER TUMOR; DISEASE COURSE; DISEASE FREE SURVIVAL; METABOLISM; MIDDLE AGED; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; TUMOR RECURRENCE;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD44; BLADDER NEOPLASMS; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGE; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL; HUMANS; MIDDLE AGED; URINARY BLADDER NEOPLASMS;

EID: 0035545321     PISSN: 03011623     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1019589923706     Document Type: Article

References (21)

1. Prognostic factors for bladder cancer
2. Biology and management of bladder cancer
3. Urothelial cancer - Mucosally confined disease can be aggressive
4. Prognostic markers in bladder cancer: A contemporary review of the literature
5. Participation in normal immune responses of metastasis-inducing splice variant of CD44
6. CD44 splice variants confer metastatic behavior in rats: Homologous sequences are expressed in human tumor cell lines
7. CD44: Structure, function, and association with the malignant process
8. Potential use of soluble CD44 in serum as indicator of tumor burden and metastasis in patients with gastric or colon cancer
9. CD44 variant exon epitopes in primary breast cancer and length of survival
10. Histological typing of urinary bladder tumours
11. An exaltation of experts: Concerted efforts in the standardization of immunohistochemistry
12. Analysis of anomalous CD44 gene expression in human breast, bladder, and colon cancer and correlation of observed mRNA and protein isoforms
13. Expression of CD44V2 in transitional cell carcinoma of the urinary bladder and in urine
14. Expressions of E-cadherin and exon v6-containing isoforms of CD44 and their prognostic values in human transitional cell carcinoma
15. Correlation of expression of CD44 isoforms and E-cadherin with differentiation in human urothelial cell lines and transitional cell carcinoma
16. Expression of CD44 standard and variant-v6 proteins in transitional cell bladder tumours and their relation to prognosis during a long-term follow-up
17. Expression of the CD44 cell adhesion molecule in urinary bladder transitional cell carcinoma
18. Focal loss of CD44 variant protein expression is related to recurrence in superficial bladder carcinoma
19. Progressive loss of CD44 gene expression in invasive bladder cancer
20. Cadherin cell adhesion receptors as a morphogenetic regulator